Patrick Yung Wen

54PUBLICATIONS
473CO-AUTHORS
Haematological tumoursPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Molecular targetsBiological adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Jul 10, 2026
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.

|Jun 12, 2026
Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma.

|Jun 03, 2026
Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma.

|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

|Apr 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Patrick Y Wen, Donald A Berry, Meredith B Buxton

|Feb 16, 2026
Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitors.

Vihang Nakhate, Catharina Westergaard, Zhou Lan

Pageof 9

Frequent Collaborators

15 joint publications

David Reardon

14 joint publications

Michael Weller

12 joint publications

Keith L Ligon

12 joint publications

Timothy F Cloughesy